NeuroPace Inc. (NPCE)
13.59
0.48 (3.66%)
At close: Apr 02, 2025, 3:59 PM
NeuroPace Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
Cash & Equivalents | 13.43M | 18.06M | 6.61M | 19.19M | 26.39M | 4.12M |
Short-Term Investments | 39.33M | 48.4M | 70.8M | 96.4M | 11.69M | 969K |
Long-Term Investments | n/a | n/a | 122K | 122K | 366K | n/a |
Other Long-Term Assets | 413K | 524K | 368K | 21K | 507K | 25K |
Receivables | 12.85M | 12.31M | 7.48M | 7.09M | 8.39M | 6.02M |
Inventory | 13.38M | 11.21M | 9.71M | 7.82M | 6.91M | 7.9M |
Other Current Assets | 2.35M | 2.74M | 3.11M | 2.32M | n/a | n/a |
Total Current Assets | 81.34M | 92.72M | 97.71M | 132.82M | 54.56M | 20.26M |
Property-Plant & Equipment | 12.89M | 14.41M | 15.9M | 603K | 515K | 810K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 13.31M | 14.93M | 16.39M | 746K | 1.39M | 835K |
Total Assets | 94.65M | 107.65M | 114.11M | 133.56M | 55.95M | 21.09M |
Account Payables | 2.95M | 2.33M | 2.15M | 1.38M | 949K | 903K |
Deferred Revenue | 555K | 1.09M | n/a | n/a | n/a | 6.73M |
Short-Term Debt | 1.86M | n/a | 1.42M | n/a | 2.04M | 62.8M |
Other Current Liabilities | 9.79M | 1.52M | 251K | 1.38M | 666K | 7.74M |
Total Current Liabilities | 15.16M | 16.23M | 10.98M | 9.3M | 9.6M | 75.15M |
Long-Term Debt | 71.48M | 56.95M | 52.91M | 49.85M | 50.82M | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 911K | 143.37M | 75.3M |
Total Long-Term Liabilities | 71.48M | 70.77M | 68.35M | 50.76M | 194.19M | 75.3M |
Total Liabilities | 86.63M | 87M | 79.33M | 60.06M | 203.78M | 150.44M |
Total Debt | 73.34M | 72.39M | 69.77M | 49.85M | 52.86M | 62.8M |
Common Stock | 30K | 28K | 25K | 24K | n/a | 1K |
Retained Earnings | -530.95M | -503.81M | -470.85M | -423.77M | -387.69M | -363.64M |
Comprehensive Income | n/a | 0.00 | -1.11M | -272K | 33K | 1K |
Shareholders Equity | 8.01M | 20.65M | 34.78M | 73.5M | -147.83M | -129.35M |
Total Investments | 39.33M | 48.4M | 70.8M | 96.4M | 11.69M | 969K |